<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01015157</url>
  </required_header>
  <id_info>
    <org_study_id>SEAM1</org_study_id>
    <nct_id>NCT01015157</nct_id>
  </id_info>
  <brief_title>Prospective Trial Using Gastric Stapling Line Reinforcement With Seamguard in Roux-en-Y Gastric Bypass</brief_title>
  <official_title>Laparoscopic Roux-en-Y Gastric Bypass Outcomes With Systematic Gastric Stapling Line Reinforcement With Seamguard Biomaterial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinique de l'Anjou</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinique de l'Anjou</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study objectives :&#xD;
&#xD;
      Primary endpoint is to a assess the change in blood loss (originating from stapling the&#xD;
      stomach) with the use of Seamguard reinforcement Secondary endpoint is to evaluate the&#xD;
      difference in leak rate&#xD;
&#xD;
      Methods :&#xD;
&#xD;
      Prospective. Randomized study. Published data does not allow for clear determination of the&#xD;
      number of patients required for the study. Based on our own experience. The investigators&#xD;
      estimate that the average postoperative blood loss is 200ml with a standard deviation of&#xD;
      100ml over 3 days. Based on this assumption. A total number of patients (control + Seamguard&#xD;
      groups) of 60 is required if the expected reduction of the mean drainage volume is 100ml and&#xD;
      82 patients for an expected drainage volume reduction of 85ml.&#xD;
&#xD;
      All patients candidates to a laparoscopic gastric bypass will be enrolled in the study Under&#xD;
      the conditions this is a primary bariatric procedure (no revision allowed)., no history of&#xD;
      hiatal surgery such as anti-reflux nor significant upper abdominal surgery. The only&#xD;
      associated surgical procedure allowed is the cholecystectomy.&#xD;
&#xD;
      Patients' inclusion :&#xD;
&#xD;
      Will be done immediately before surgical procedure following acceptance of a written consent.&#xD;
&#xD;
      Bleeding from liver or slpeen injury will lead to patient's exclusion.&#xD;
&#xD;
      Methods :&#xD;
&#xD;
      Surgical procedures are identical for the 2 surgeons of the study (GB and PT) with 30-50ml&#xD;
      gastric pouch. Linear. side to side. Antegastric and antecolic gastrojejunal anstomosis . Use&#xD;
      of Echelon 60 linear stapler with GOLD cartridges on stomach. Blue to perform the&#xD;
      gastrojejunal anastomosis and white on Small bowel. Peroperativeblood loss and need to apply&#xD;
      clips or stitches on the gastric staple line are recorded. Operation time and patient&#xD;
      information (BMI. Comorbidities) are recorded as well any noticeable or unexpected event.&#xD;
&#xD;
      Postoperative blood loss is assessed by at least 1 abdominal closed circuit suction drain&#xD;
      left for a minimum of 3 days (removal on postop day 3 at the earliest).&#xD;
&#xD;
      In addition hemoglobin and red cell count is performed on postop day 1 and 2. Absence of&#xD;
      leakage is confirmed by methylene blue test perop as well as on postop day 1 before resuming&#xD;
      fluids and on postop day 2 by a gastrograffin swallow. Drinks and food are resumed according&#xD;
      to the standard practice between postop day 1 and postop day 2.&#xD;
&#xD;
      Duration of the hospital stay and postoperative course will be documented. Early follow up is&#xD;
      clinically done at 1 month postop without any specific radiological or biological&#xD;
      examination.&#xD;
&#xD;
      Data collection Will be done on a form during and after the procedure&#xD;
&#xD;
      BLOOD LOSS : peroperative volume as well as daily drainage output (postop day 1. 2 and 3) as&#xD;
      well as the sum of the 3 postop days.&#xD;
&#xD;
      Hemoglobin change is recorded on day 1 and 2. Need to leave drain(s) for more than 3 days is&#xD;
      recorded.&#xD;
&#xD;
      Study completion :&#xD;
&#xD;
      Estimated time to complete the study based on the current experience is between 5 and 7&#xD;
      months. Sudy is closed 1 month after the last inclusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss volume per and postoperatively, additional hemostatic measures peroperatively, hemoglobin levels postoperatively</measure>
    <time_frame>3 days postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>gastrojejunal anastomosis leakage rate: clinical and radiological</measure>
    <time_frame>postoperative day 2 (gastrograffin swallow)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>Standard stapling without reinforcement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Echelon 60 linear stapling with GOLD cartridges</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Seamguard gastric stapling line reinforcement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y laparoscopic gastric bypass for morbid obesity</intervention_name>
    <description>Primary bariatric surgery. Standard laparoscopic procedure with linear stapling divising of the stomach (Echelon 60 stapler, GOLD cartridges) with or with Seamguard reinforcement</description>
    <arm_group_label>Seamguard gastric stapling line reinforcement</arm_group_label>
    <arm_group_label>Standard stapling without reinforcement</arm_group_label>
    <other_name>Gore Seamguard biomaterial staple line reinforcement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all primary laparoscopic Roux-en-Y gastric bypasses for morbid obesity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  additional procedures except cholecystectomy, peroperative bleeding from spleen or&#xD;
             liver injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe A Topart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Société de Chirurgie Viscérale</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique de l'Anjou</name>
      <address>
        <city>Angers</city>
        <zip>49044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <study_first_submitted>August 5, 2009</study_first_submitted>
  <study_first_submitted_qc>November 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2009</study_first_posted>
  <last_update_submitted>January 4, 2010</last_update_submitted>
  <last_update_submitted_qc>January 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Philippe Topart MD</name_title>
    <organization>Société de Chirurgie Viscérale, Clinique de l'Anjou</organization>
  </responsible_party>
  <keyword>Gastric bypass</keyword>
  <keyword>staple line reinforcement</keyword>
  <keyword>outcomes</keyword>
  <keyword>per and postoperative blood loss</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

